These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23670717)
21. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma. Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276 [TBL] [Abstract][Full Text] [Related]
22. Clinical significance of decreased nidogen-2 expression in the tumor tissue and serum of patients with hepatocellular carcinoma. Cheng ZX; Huang XH; Wang Q; Chen JS; Zhang LJ; Chen XL J Surg Oncol; 2012 Jan; 105(1):71-80. PubMed ID: 21815147 [TBL] [Abstract][Full Text] [Related]
23. OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma. Wu D; Yang X; Peng H; Guo D; Zhao W; Zhao C; Zhou X Carcinogenesis; 2017 Sep; 38(9):910-919. PubMed ID: 28911005 [TBL] [Abstract][Full Text] [Related]
24. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas. Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326 [TBL] [Abstract][Full Text] [Related]
25. [Expression and clinicopathological significance of GRAMD4 in hepatocellular carcinoma]. Zhang J; Tu K; Zhou Z; Zheng X; Gao J; Yao Y; Liu Q Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):190-3. PubMed ID: 23388340 [TBL] [Abstract][Full Text] [Related]
26. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence. Sun CK; Ng KT; Sun BS; Ho JW; Lee TK; Ng I; Poon RT; Lo CM; Liu CL; Man K; Fan ST Br J Cancer; 2007 Jul; 97(1):50-7. PubMed ID: 17551499 [TBL] [Abstract][Full Text] [Related]
27. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma. Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969 [TBL] [Abstract][Full Text] [Related]
28. Expression of NEDD9 in hepatocellular carcinoma and its clinical significance. Lu P; Wang ZP; Dang Z; Zheng ZG; Li X; Zhou L; Ding R; Yue SQ; Dou KF Oncol Rep; 2015 May; 33(5):2375-83. PubMed ID: 25812772 [TBL] [Abstract][Full Text] [Related]
29. [Correlation between epigenetic alterations in the insulin growth factor-II gene and hepatocellular carcinoma]. Dong ZZ; Yao DF; Wu W; Qiu LW; Yao NH; Yan XD; Yu DD; Chen J Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):593-7. PubMed ID: 23207153 [TBL] [Abstract][Full Text] [Related]
30. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma. Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370 [TBL] [Abstract][Full Text] [Related]
32. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof]. Shen HW; Wu YL; Peng SY Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749 [TBL] [Abstract][Full Text] [Related]
33. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. Li XM; Tang ZY; Zhou G; Lui YK; Ye SL J Exp Clin Cancer Res; 1998 Mar; 17(1):13-7. PubMed ID: 9646228 [TBL] [Abstract][Full Text] [Related]
34. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients]. Zhou Q; Liang LJ; Peng BG; Zhen YY Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916 [TBL] [Abstract][Full Text] [Related]
35. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma]. Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068 [TBL] [Abstract][Full Text] [Related]
36. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma. Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579 [TBL] [Abstract][Full Text] [Related]
37. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469 [TBL] [Abstract][Full Text] [Related]
38. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma. Li Q; Xu B; Fu L; Hao XS J Exp Clin Cancer Res; 2006 Sep; 25(3):403-9. PubMed ID: 17167981 [TBL] [Abstract][Full Text] [Related]
39. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma. Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489 [TBL] [Abstract][Full Text] [Related]
40. [RNA interference targeting focal adhesion kinase inhibited the growth of human hepatocellular carcinoma sk-hep-1]. Xu WJ; Zhang S; Zhang N; Yang Y; Wei YQ; Deng HX Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):455-60. PubMed ID: 21866625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]